C Brouzes
Overview
Explore the profile of C Brouzes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Djelbani-Ahmed S, Chandesris M, Mekinian A, Canioni D, Brouzes C, Hanssens K, et al.
Eur J Nucl Med Mol Imaging
. 2015 Jul;
42(13):2013-20.
PMID: 26140850
Introduction: Mastocytosis is a clonal haematological disease characterized by uncontrolled proliferation and the activation of mast cells. The value of FDG-PET/CT (FDG-PET) in mastocytosis has yet to be determined. Methods:...
2.
Fossat C, Roussel M, Arnoux I, Asnafi V, Brouzes C, Garnache-Ottou F, et al.
Cytometry B Clin Cytom
. 2014 Oct;
PMID: 25270227
Background: Minimal residual disease (MRD) assessment provides a powerful prognostic factor for therapeutic stratification in acute lymphoblastic leukemia (ALL). Multiparameter flow cytometry (MFC) has the potential for a rapid and...
3.
Morel N, Georgin-Lavialle S, Levesque K, Guettrot-Imbert G, Le Guern V, Le Bidois J, et al.
Rev Med Interne
. 2014 Sep;
36(3):159-66.
PMID: 25240481
Neonatal lupus syndrome is associated with transplacental passage of maternal anti-SSA/Ro and anti-SSB/La antibodies. Children display cutaneous, hematological, liver or cardiac features. Cardiac manifestations include congenital heart block (CHB); endocardial...
4.
Brousse V, Brouzes C, Sicre de Fontbrune F, Casadevall N, Varet B
Ann Hematol
. 2013 Feb;
92(9):1289-90.
PMID: 23408098
No abstract available.
5.
Garand R, Beldjord K, Cave H, Fossat C, Arnoux I, Asnafi V, et al.
Leukemia
. 2012 Oct;
27(2):370-6.
PMID: 23070018
Minimal residual disease (MRD) quantification is widely used for therapeutic stratification in pediatric acute lymphoblastic leukemia (ALL). A robust, reproducible, sensitivity of at least 0.01% has been achieved for IG/TCR...
6.
de Montalembert M, Bresson J, Brouzes C, Ruemmele F, Puy H, Beaumont C
Arch Pediatr
. 2012 Feb;
19(3):295-304.
PMID: 22310020
Iron deficiency is the most frequent cause of hypochromic microcytic anemia in children, but other causes, some of them requiring specific management, may be involved. Checking the iron-status is absolutely...
7.
Ossard-Receveur A, Bernheim A, Clausse B, Danglot G, Fauvet D, Leon B, et al.
Cancer Genet Cytogenet
. 2005 Dec;
163(2):189-90.
PMID: 16337868
No abstract available.
8.
Lavollay M, Gouin I, Brouzes C, Andreux M, Andreux J, Laurent M, et al.
Ann Biol Clin (Paris)
. 2001 Nov;
59(6):761-3.
PMID: 11713023
No abstract available.
9.
Biousse V, Conard J, Brouzes C, Horellou M, Ameri A, Bousser M
Stroke
. 1998 Jul;
29(7):1398-400.
PMID: 9660394
Background And Purpose: A novel sequence variation in the 3'-untranslated region of the prothrombin (factor II) gene (nucleotide 20210 G-->A) has been recently described as a risk factor for deep...